Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer

Overview of attention for article published in Breast Cancer Research, June 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

news: 1 news outlet

twitter: 4 X users

Readers on

mendeley: 32 Mendeley

Summary News X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 2,945 followers.

Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer https://t.co/xlj7CWMhRz

18 Dec 2020

Reply Repost Favourite

RT @MammaryCell: Targeting Tumor Re-Wiring by Triple Blockade of mTORC1, Epidermal Growth Factor, & Oestrogen Receptor Signaling Pathways i…

19 Jun 2018

Reply Repost Favourite

Targeting Tumor Re-Wiring by Triple Blockade of mTORC1, Epidermal Growth Factor, & Oestrogen Receptor Signaling Pathways in Endocrine-Resistant #BreastCancer @ICR_London https://t.co/AZ6INdKkmG

19 Jun 2018

Reply Repost Favourite

Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer. https://t.co/yyaRLSQYkm

09 Jun 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.